Justin Trudeau Celebrates Opening Of Canada’s Largest Vaccine Manufacturing Plant

Canada has officially opened its largest vaccine production plant.

Backed by a federal investment of $20 million, Sanofi will open a “new state-of-the-art Vaccine Manufacturing Facility in Toronto, Ontario.”

“Vaccines save lives. During the COVID-19 pandemic, millions of Canadians came together, rolled up their sleeves and got their shots. And because of this teamwork, we got through the pandemic. But as we look back on the past few years, one thing is clear – we need to make more vaccines here in Canada, and we need to be able to make them fast,” Prime Minister of Canada Justin Trudeau said in a news release.

The new Sanofi facility is the largest in Canada and is expected to significantly increase Canada’s domestic production of pediatric and adult vaccines https://t.co/H9LD1UhvqS

— CityNews Toronto (@CityNewsTO) May 30, 2024

According to Trudeau, the plant will be “one of the most advanced vaccine manufacturing facilities in the world.”

“Vaccines save lives. That’s why we’ll be producing a lot more of them in Canada, including flu vaccines. Sanofi’s two new facilities in Toronto will create good-paying jobs, protect the health and well-being of Canadians, and give our scientists, innovators, and researchers a fair chance to succeed,” Trudeau said.

“Our government is pleased to support Sanofi as they expand their footprint in Ontario. This new state-of-the-art facility is another vote of confidence in our workers and our growing life sciences sector, helping to ensure people in Ontario and around the world have increased access to life-saving vaccines when they need them,” Ontario Premier Doug Ford said.

Today’s opening of @SanofiCanada’s advanced vaccine manufacturing facility will help strengthen Canada’s biomanufacturing capacity, protect the health of Canadians, and create good-paying jobs. Learn more: https://t.co/7bzIPCIwg7

— CanadianPM (@CanadianPM) May 30, 2024

From Prime Minister of Canada Justin Trudeau:

As the largest biomanufacturing facility in Canadian history, it will help the company expand the production of its life-saving vaccines. It will produce whooping cough, tetanus, and diphtheria vaccines for Canada and 60 international markets. And it will create over 200 good-paying jobs as well as support and maintain over 1000 other jobs in Ontario.

We’re investing in biomanufacturing, enabling breakthrough science, creating jobs, and producing the life-saving medicines that’ll keep Canadians healthy, right here in Canada. It’s a win for public health, a win for science, a win for our innovators and researchers, and a win for Canadian families.

And we’re not stopping there. This is just the first of two advanced vaccine manufacturing facilities the company is building in Toronto, Ontario. With a $415 million investment from our Strategic Innovation Fund, we’re helping Sanofi build a new end-to-end flu vaccine manufacturing facility. Once operational, this facility will be able to produce enough vaccine doses to protect our entire population within six months of a pandemic flu strain being identified by the World Health Organization. This will make sure we’re better prepared for health emergencies, better protected against outbreaks, and better placed to get vaccines to Canadians, faster.

Strengthening our biomanufacturing and life sciences sector across the country will help re-establish Canada’s vaccine manufacturing capability, get them to families faster, and give our health scientists a fair chance to make groundbreaking discoveries – all while growing the economy and creating good jobs.

“Sanofi, a global biopharmaceutical company, received $415 million from Canada and another $55 million from the Ontario government, to build a flu vaccine and pandemic preparedness plant at its Toronto campus by 2026,” Global News noted.

Justin Trudeau announced the opening of a major vaccine production plant in Toronto Thursday— part of Canada’s efforts to build up its domestic biomanufacturing sector.

READ MORE: https://t.co/xYNgHT3DURhttps://t.co/xYNgHT3DUR

— Globalnews.ca (@globalnews) May 30, 2024

Per Global News:

The company says that facility will be ready in 2027.

Between May 2020 and April 2022, Canada promised more than $1.3 billion for 12 new or expanded biomanufacturing plants to make vaccines and antibody treatments.

ADVERTISEMENT

This is a Guest Post from our friends over at 100 Percent Fed Up.

View the original article here.